Essential thrombocythemia. Therapy with interferon alfa.

Authors

  • L Lebre Serviço de Medicina Interna, Hospital Sa. Cruz, Carnaxide.
  • A Sousa
  • J Sampaio
  • L Novais
  • E Júnior
  • R Coelho
  • J Simões

DOI:

https://doi.org/10.20344/amp.3353

Abstract

A clinical case of essential thrombocythaemia is presented to demonstrate good therapeutic response to subcutaneous Alpha-2b Interferon in a dosage of 3 x 10(6) units, three times a week. Based on this case and on a literature research we propose that Alpha-2b Interferon is a legitimate alternative to alkylating agents or radioactive phosphorus (32P), showing identical efficacy and less Leukemogen effect.

Downloads

Download data is not yet available.

How to Cite

1.
Lebre L, Sousa A, Sampaio J, Novais L, Júnior E, Coelho R, Simões J. Essential thrombocythemia. Therapy with interferon alfa. Acta Med Port [Internet]. 1991 Aug. 30 [cited 2024 Mar. 28];4(4):208-10. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/3353

Issue

Section

Arquivo Histórico